Agentic AI Clinical Systems — Architecture, Evidence Gaps, and Governance Concerns (2026)
CONCEPTContent
Overview
2026 has emerged as a pivotal year for scaling enterprise clinical AI from pilot programs to production deployment. The challenge of moving "beyond the pilot" requires addressing not just technical performance but organizational, governance, and infrastructure readiness.
Architecture for Scale
Scaling clinical AI in enterprise health systems requires robust data pipelines, EHR integration, model monitoring infrastructure, and change management capabilities. The technical architecture must support not just initial deployment but ongoing model maintenance, drift detection, and version control as clinical AI systems evolve.
Healthcare Customer Experience and Agentic AI
IntrepidGP's Derby Mill team, in discussion with League CEO Michael Serbinis, has explored how healthcare customer experience (CX) may ultimately lead to "super-capable medical agentic AI" — systems that not only respond to queries but proactively manage patient journeys. This represents the far end of the agentic AI spectrum, where systems act with substantial autonomy on behalf of patients and health systems.
LLM Performance Assessment
Signal 1 CEO Tomi Poutanen has engaged with the challenge of assessing LLM performance specifically in healthcare platform contexts, highlighting that standard benchmarks may not capture the performance characteristics most relevant to clinical deployment. This is a critical gap as health systems make purchasing and build decisions based on available evidence.
Governance Gaps
Enterprise scaling amplifies governance challenges — a model that performs adequately in a pilot may produce significant harm at scale if edge cases are more frequently encountered. Governance frameworks must scale with deployment, including real-time monitoring, clear escalation protocols, and regular performance audits.